Diabetic retinopathy can lead to peripheral or nighttime vision loss, visual disturbances, and, if left untreated, blindness.

APX-3330 is under clinical development by Opus Genetics and currently in Phase II for Non-Proliferative Diabetic Retinopathy (NPDR).

OCX-063 is under clinical development by OccuRx and currently in Phase I for Diabetic Retinopathy. According to GlobalData, Phase I drugs for Diabetic Retinopathy have a 78% phase transition success ...

India, which is seeing a surge in diabetes cases, is also witnessing a rise in diabetic retinopathy, a condition that damages ...

Although laser photocoagulation is an effective treatment for proliferative diabetic retinopathy, few options were available at that time for wet AMD (Box 1). Visual acuity tests are the most ...

"Empagliflozin could be beneficial in slowing down progression to more advanced stages of diabetic ... prior diagnosis or treatment for proliferative diabetic retinopathy or other advanced retinal ...

and progression of diabetic retinopathy, defined as a composite of treatment initiation or onset of vitreous hemorrhage or proliferative diabetic retinopathy. During a mean follow-up period of 8 ...